Market Tracker

07/07 7:55am ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

128.83
Delayed Data
As of Jul 06
 -2.43 / -1.85%
Today’s Change
84.41
Today|||52-Week Range
137.50
+8.44%
Year-to-Date

Today’s Trading

Previous close131.26
Today’s open128.95
Day’s range-- - --
Volume2,264,618
Average volume (3 months)1,485,375
Market cap$32.0B
Dividend yield--
Data as of 07/06/2015

Growth & Valuation

Earnings growth (last year)-58.59%
Earnings growth (this year)+43.00%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales48.16
Price/Book29.52

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+0.63+0.90%
PRGOPerrigo Company PLC+1.98+1.08%
ZTSZoetis Inc+0.09+0.19%
ALXNAlexion Pharmaceutic...+1.02+0.55%
Data as of 07/06/2015

Financials

Next reporting dateJuly 27, 2015
EPS forecast (this quarter)-$0.76
Annual revenue (last year)$580.4M
Annual profit (last year)-$738.6M
Net profit margin-127.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts